Choi JM - Search Results

1

HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics.

Choi JM, Oh SJ, Lee SY, Im JH, Oh JM, Ryu CS, Kwak HC, Lee JY, Kang KW, Kim SK. Choi JM, et al. Arch Pharm Res. 2015;38(5):691-704. doi: 10.1007/s12272-014-0502-6. Epub 2014 Oct 22. Arch Pharm Res. 2015. PMID: 25336106

2

Hepatic expression of cytochrome P450 in type 2 diabetic Goto-Kakizaki rats.

Oh SJ, Choi JM, Yun KU, Oh JM, Kwak HC, Oh JG, Lee KS, Kim BH, Heo TH, Kim SK. Oh SJ, et al. Among authors: choi jm. Chem Biol Interact. 2012 Feb 5;195(3):173-9. doi: 10.1016/j.cbi.2011.12.010. Epub 2012 Jan 5. Chem Biol Interact. 2012. PMID: 22244987

3

Prediction of Drug-Induced Liver Injury in HepG2 Cells Cultured with Human Liver Microsomes.

Choi JM, Oh SJ, Lee JY, Jeon JS, Ryu CS, Kim YM, Lee K, Kim SK. Choi JM, et al. Chem Res Toxicol. 2015 May 18;28(5):872-85. doi: 10.1021/tx500504n. Epub 2015 Apr 17. Chem Res Toxicol. 2015. PMID: 25860621

4

Effects of palmitic acid on TNF-α-induced cytotoxicity in SK-Hep-1 cells.

Oh JM, Choi JM, Lee JY, Oh SJ, Kim HC, Kim BH, Ma JY, Kim SK. Oh JM, et al. Among authors: choi jm. Toxicol In Vitro. 2012 Sep;26(6):783-90. doi: 10.1016/j.tiv.2012.05.013. Epub 2012 Jun 7. Toxicol In Vitro. 2012. PMID: 22683933

5

Role of NADPH oxidase-4 in saturated fatty acid-induced insulin resistance in SK-Hep-1 cells.

Oh JM, Choi JM, Lee JY, Oh SJ, Kim BH, Kim SK. Oh JM, et al. Among authors: choi jm. Food Chem Toxicol. 2014 Jan;63:128-35. doi: 10.1016/j.fct.2013.10.049. Epub 2013 Nov 8. Food Chem Toxicol. 2014. PMID: 24211519

6

GPR119: a promising target for nonalcoholic fatty liver disease.

Yang JW, Kim HS, Im JH, Kim JW, Jun DW, Lim SC, Lee K, Choi JM, Kim SK, Kang KW. Yang JW, et al. Among authors: choi jm. FASEB J. 2016 Jan;30(1):324-35. doi: 10.1096/fj.15-273771. Epub 2015 Sep 23. FASEB J. 2016. PMID: 26399788

7

Biphasic Effects of Ingenol 3,20-Dibenzoate on the Erythropoietin Receptor: Synergism at Low Doses and Antagonism at High Doses.

Oh JG, Chin YW, Kim SJ, Choi JM, Kim SK, Kang HE, Heo TH. Oh JG, et al. Among authors: choi jm. Mol Pharmacol. 2015 Aug;88(2):392-400. doi: 10.1124/mol.114.097436. Epub 2015 Jun 5. Mol Pharmacol. 2015. PMID: 26048958

8

Identification and evaluation of neutral sphingomyelinase 2 inhibitors.

Lee DH, Kim SH, Ahn KH, Kim SK, Choi JM, Ji JE, Won JH, Park YH, Lim C, Kim S, Kim DK. Lee DH, et al. Among authors: choi jm. Arch Pharm Res. 2011 Feb;34(2):229-36. doi: 10.1007/s12272-011-0208-y. Epub 2011 Mar 6. Arch Pharm Res. 2011. PMID: 21380806

9

Age-related effects of sodium arsenite on splenocyte proliferation and Th1/Th2 cytokine production.

Cho Y, Ahn KH, Back MJ, Choi JM, Ji JE, Won JH, Fu Z, Jang JM, Kim DK. Cho Y, et al. Among authors: choi jm. Arch Pharm Res. 2012 Feb;35(2):375-82. doi: 10.1007/s12272-012-0219-3. Epub 2012 Feb 28. Arch Pharm Res. 2012. PMID: 22370793

10

Protective effect of sesquiterpene lactone parthenolide on LPS-induced acute lung injury.

Jang YJ, Back MJ, Fu Z, Lee JH, Won JH, Ha HC, Lee HK, Jang JM, Choi JM, Kim DK. Jang YJ, et al. Among authors: choi jm. Arch Pharm Res. 2016 Dec;39(12):1716-1725. doi: 10.1007/s12272-016-0716-x. Epub 2016 Oct 18. Arch Pharm Res. 2016. PMID: 27757770

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

763 results

Search Page